3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dejerine-Thomas Syndrome

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dejerine-Thomas Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cordes, M; Felix, R; Harisch, C; Hierholzer, J; Hosten, N; Keske, U; Mäurer, J; Poewe, W; Richter, W; Schelosky, L; Venz, S	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dejerine-Thomas Syndrome

Article	Year
Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6 Topics: Adult; Aged; Benzamides; Binding Sites; Contrast Media; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Observer Variation; Olivopontocerebellar Atrophies; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reproducibility of Results; Supranuclear Palsy, Progressive; Syndrome; Time Factors; Tomography, Emission-Computed, Single-Photon	1998

Article

Year

Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6

Topics: Adult; Aged; Benzamides; Binding Sites; Contrast Media; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Observer Variation; Olivopontocerebellar Atrophies; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reproducibility of Results; Supranuclear Palsy, Progressive; Syndrome; Time Factors; Tomography, Emission-Computed, Single-Photon

1998